Effects of Argon-plasma Jet on the Cytoskeleton of Fibroblasts: Implications of a New Approach for Cancer Therapy
![]() |
Han, Ji-Hye
(Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea)
Nam, Min-Kyung (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) Kim, Yong-Hee (Plasma Bioscience Research Center, Kwangwoon University) Park, Dae-Wook (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) Choi, Eun Ha (Plasma Bioscience Research Center, Kwangwoon University) Rhim, Hyangshuk (Department of Medical Life Sciences, Department of Biomedical Sciences, College of Medicine, the Catholic University of Korea) |
1 | Kim, S. H., J. H. Kim, B. K. Kang, and H. S. Uhm (2005) Superhydrophobic CFx coating via in-line atmospheric RF plasma of He-CF4-H2. Langmuir. 21: 12213-12217. DOI |
2 | Kilmer, S., N. Semchyshyn, G. Shah, and R. Fitzpatrick (2007) A pilot study on the use of a plasma skin regeneration device (Portrait PSR3) in full facial rejuvenation procedures. Lasers Med. Sci. 22: 101-109. DOI |
3 | Potter, M. J., et al. (2007) Facial acne and fine lines: transforming patient outcomes with plasma skin regeneration. Ann. Plast Surg. 58: 608-613. DOI |
4 | Bogle, M. A., K. A. Arndt, and J. S. Dover (2007) Evaluation of plasma skin regeneration technology in low-energy full-facial rejuvenation. Arch. Dermatol. 143: 168-174. DOI |
5 | Grund, K. E., D. Storek, and G. Farin (1994) Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc. Surg. Allied Technol. 2: 42-46. |
6 | Klein, C. A. (2008) Cancer. The metastasis cascade. Science 321: 1785-1787. DOI |
7 | Chiang, A. C. and J. Massague (2008) Molecular basis of metastasis. N. Engl. J. Med. 359: 2814-2823. DOI |
8 | Kedrin, D., J. van Rheenen, L. Hernandez, J. Condeelis, and J. E. Segall (2007) Cell motility and cytoskeletal regulation in invasion and metastasis. J. Mammary Gland Biol. Neoplasia 12: 143-152. DOI |
9 | Rhodes, L. V., et al. (2011) Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res. 71: 603-613. DOI |
10 | Entschladen, F., Drell, T. L. t., Lang, K., Joseph, J., and Zaenker, K. S. (2004) Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 5: 254-258. DOI ScienceOn |
11 | Olson, M. F. and E. Sahai (2009) The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26: 273-287. DOI |
12 | Nobes, C. D. and A. Hall (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81: 53-62. DOI ScienceOn |
13 | Wennerberg, K. and C. J. Der (2004) Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117: 1301-1312. DOI |
14 | Fritz, G., C. Brachetti, F. Bahlmann, M. Schmidt, and B. Kaina (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87: 635-644. DOI |
15 | Frixione, E. (2000) Recurring views on the structure and function of the cytoskeleton: a 300-year epic. Cell Motil Cytoskeleton 46: 73-94. DOI |
16 | Jordan, M. A. and Wilson, L. (1998) Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol. 10: 123-130. DOI ScienceOn |
17 | Doherty, G. J. and H. T. McMahon (2008) Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu. Rev. Biophys. 37: 65-95. DOI |
18 | Fuchs, E. and D. W. Cleveland (1998) A structural scaffolding of intermediate filaments in health and disease. Science 279: 514-519. DOI |
19 | Suresh, S. (2007) Biomechanics and biophysics of cancer cells. Acta Biomater 3: 413-438. DOI |
20 | Sharma, S., et al. (2012) Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells. Nanomedicine 8: 757-766. DOI |
21 | Statsuk, A. V., et al. (2005) Actin is the primary cellular receptor of bistramide A. Nat. Chem Biol. 1: 383-388. DOI |
22 | Hayot, C., et al. (2006) Characterization of the activities of actinaffecting drugs on tumor cell migration. Toxicol Appl Pharmacol. 211: 30-40. DOI ScienceOn |
23 | Coue, M., S. L. Brenner, I. Spector, and E. D. Korn (1987) Inhibition of actin polymerization by latrunculin A. FEBS Lett. 213: 316-318. DOI ScienceOn |
24 | Hemstreet, G. P., 3rd, et al. (1996) G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J. Cell Biochem. Suppl. 25: 197-204. |
25 | Baskar, R., K. A. Lee, R. Yeo, and K. W. Yeoh (2012) Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9: 193-199. DOI |
26 | DeVita, V. T., Jr. and E. Chu (2008) A history of cancer chemotherapy. Cancer Res. 68: 8643-8653. DOI |
![]() |